Sever Pharma Solutions is one of the few CDMOs specializing in controlled release systems for highly potent drugs, offering end-to-end services. The company's expertise encompasses the development of new products across various stages of development and the manufacturing of commercial products. Sever Pharma Solutions specializes in Polymer-based sustained release dosage forms such as rings and implants, aseptic Fill and Finish of High Potent drug products, and Hot Melt Extrusion as a solubility enhancement solution for poorly soluble drugs.
Looking for a particular QPharma AB employee's phone or email?
QPharma AB Questions
The QPharma AB annual revenue was $22 million in 2026.
Fredrik Hultenius is the CEO of QPharma AB.
200 people are employed at QPharma AB.
QPharma AB is based in Malmoe, Skane.
The NAICS codes for QPharma AB are [3254, 325, 32541, 32].
The SIC codes for QPharma AB are [283, 28].
Top QPharma AB Employees
-
Niklas Ellerström
CFO at QPharma AB
Malmö, SE33 -
Ulrike Foley
Head, Global Business Development and Marketing at QPharma AB
Chapel Hill, NC, US25+ -
Paul Bram
Head of IT at QPharma AB
Malmö, SE2 -
23
Related Companies
